0105 GMT - IHH Healthcare is poised for continued growth, supported by a planned 28% increase in hospital bed capacity by 2028, mainly in Malaysia and India, Hong Leong IB analyst Chee Kok Siang says in a note. In Singapore and Hong Kong, IHH plans to expand across the care continuum with a focus on ambulatory and primary care, while also aiming to turn around its China operations, he says. Ongoing refurbishments at Singapore's Mount Elizabeth Hospital at Orchard may pressure margins until 2Q, he adds. Management remains open to merger-and-acquisition opportunities, targeting value-accretive assets in Malaysia, India, Turkey, and Europe, he notes. Hong Leong raises IHH's target price to MYR9.06 from MYR9.03 while maintaining a buy rating on the stock. Shares are 0.7% lower at MYR6.86.(yingxian.wong@wsj.com)
(END) Dow Jones Newswires
May 29, 2025 21:05 ET (01:05 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.